Financial Highlights for the First Quarter of 2026
- On
February 24, 2026 , Matrix IT Ltd. (“Matrix”) andMagic Software Enterprises Ltd. (“Magic Software”), both subsidiaries of the Company, announced the completion of their merger agreement. The transaction, which was effected through a reverse triangular merger, resulted in Matrix acquiring all of the issued and outstanding share capital ofMagic Software in consideration for the allotment of 28,861,564 ordinary shares of Matrix to Magic Software’s shareholders (0.5878202 Matrix ordinary shares for eachMagic Software ordinary share). Following completion of the merger,Magic Software became a wholly owned (100%) subsidiary of Matrix, its shares were delisted from trading on Nasdaq and the Tel Aviv Stock Exchange, and it ceased to be a public company. - Revenues for the first quarter ended
March 31, 2026 increased by 19.2% year over year, reaching a first quarter record-breaking$738.3 million , compared to$619.4 million in the same period last year. - Operating income for the first quarter ended
March 31, 2026 increased by 65.6% year over year, reaching a first quarter record-breaking$82.0 million compared to$49.5 million in the same period last year. Operating income for the first quarter of 2026 included a capital gain of$16.8 million resulting from exercise of employee stock-based compensation and a secondary private placement transaction completed by our affiliate, TSG IT Advanced Systems Ltd. (“TSG”), inJanuary 2026 . OnJanuary 13, 2026 , TSG’s Board of Directors approved a capital raise through a private placement to institutional investors, pursuant to which TSG raised approximatelyNIS 192 million (approximately$58.9 million ) through the issuance of 320,374 ordinary shares at a price ofNIS 600 per share, together with 128,150 non-tradable warrants (allocated at no additional consideration at a ratio of 0.4 warrant per share), each exercisable for one ordinary share at an exercise price ofNIS 720 per share throughJuly 22, 2027 . The terms of the private placement also provides for a potential additional investment by the institutional investors of approximatelyNIS 92 million (approximately$29.1 million ) in the event all warrants are fully exercised. The allocated shares and warrants represent approximately 9.23% of TSG’s fully diluted share capital. As a result of this transaction and the exercise of TSG’s employee stock-based compensation,during the first quarter of 2026 Formula’s ownership interest in TSG was diluted from 37.33% to 33.08%, causing the$16.8 million capital gain. Excluding this capital gain, operating income would have increased by 31.7% year over year, to$65.2 million . - Net income from continued operations attributable to Formula’s shareholders for the first quarter ended
March 31, 2026 , increased by approximately 203.4% year over year, reaching a first quarter record-breaking$35.6 million , or$2.25 per fully diluted share, compared to$11.7 million , or$0.75 per fully diluted share, in the same period last year. Excluding the impact of the capital gain resulting from TSG’s secondary private placement transaction and the exercise of TSG’s employee stock-based compensation, net income from continued operations attributable to Formula’s shareholders would have increased by 60.5% year over year, to$18.9 million . - Net income attributable to Formula’s shareholders for the first quarter ended
March 31, 2026 increased by approximately 84.5% year over year, reaching a first quarter record-braking$35.6 million , or$2.25 per fully diluted share, compared to$19.3 million , or$1.23 per fully diluted share, in the same period last year. - On
May 14, 2026 , Formula announced that its board of directors has approved the distribution of a special cash dividend, based on its results for 2025, including, in particular, the completion of the acquisition of Formula’s former subsidiarySapiens International Corporation (“Sapiens”) by Advent, of$13.045 per share, or approximately$200.0 million in total. The dividend will be paid inU.S dollars onJune 4, 2026 , to all of the Company’s shareholders of record at the close of trading on the Nasdaq Global Select Market (or the Tel-Aviv Stock Exchange, as appropriate) onMay 25, 2026 . - As of
March 31, 2026 , Formula held 47.67%, 18.68%, 69.09%, 33.08%, 90.09%, 80%, 100%, 100%, 51% and 100% of the outstanding ordinary shares of Matrix IT Ltd.,SI Swan UK Topco Limited ., Michpal Technologies Ltd., TSG IT Advanced Systems Ltd.,Insync Staffing, Inc. ,Ofek Aerial Photography Ltd. ,ZAP Group Ltd. , Shamrad Electronic (1997) Ltd.,Hashahar Telecom And Electricity Ltd. , andFormula Infrastructure Ltd. , respectively. - Consolidated cash and cash equivalents and short-term bank deposits totaled approximately
$1 .18 billion as ofMarch 31, 2026 , compared to$1 .28 billion as ofDecember 31, 2025 . - Total equity as of
March 31, 2026 was$1.82 billion (representing 50.1% of the total consolidated statements of financial position), compared to$1.78 billion (representing 49.6% of the total consolidated statements of financial position) as ofDecember 31, 2025 . - The above comparative figures for the first quarter ended
March 31, 2025 reflect the reclassification of the results of Sapiens (of which Formula sold its controlling interest inDecember 2025 ), as discontinued operations, in accordance with IFRS 5. Similarly, the Company’s record-breaking consolidated results for the quarter endedMarch 31, 2026 (as described above) are relative to the Company’s historical consolidated results in prior years that exclude Sapiens.
Debentures Covenants
As of
Covenant 1
- Target equity attributable to Formula’s shareholders (excluding non-controlling interests): above
$325 million . - Actual equity attributable to Formula’s shareholders as of
March 31, 2026 was$1.38 billion .
Covenant 2
- Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for Formula’s Series C and D Secured Debentures): below 65%.
- Actual ratio of net financial indebtedness to net capitalization, as of
March 31, 2026 was (55.46%).
Covenant 3
- Target ratio of net financial indebtedness to EBITDA (based on the accumulated calculation for the four most recent quarters): below 5.
- Actual ratio of net financial indebtedness to EBITDA as of
March 31, 2026 was (376.94%).
Comments of Management
Commenting on the results,
“Matrix reported a strong start to 2026 in its first quarter following the completion of the merger with
“Michpal Technologies opened 2026 with a strong first quarter, reflecting continued growth across all financial metrics and demonstrating its ability to leverage synergies and expand revenues and profits across it two business segments. With a solid cash position of approximately
“TSG opened 2026 with record-breaking first quarter results, demonstrating continued significant growth in revenues and profits across its business segments. Revenues for the first quarter of 2026 increased by approximately 19.4% year over year to a record-breaking
Stand-Alone Financial Measures
This press release presents, further below, certain stand-alone financial measures to reflect Formula’s stand-alone financial position in reference to its assets and liabilities as the parent company of its group of companies. These financial measures are prepared consistently with the accounting principles applied in the consolidated financial statements of the group. Such measures include investments in subsidiaries and a jointly controlled entity measured at cost adjusted by Formula’s share in the investees’ accumulated undistributed earnings and other comprehensive income or loss.
Formula believes that these financial measures provide useful information to management and investors regarding Formula’s stand-alone financial position. Formula’s management uses these measures to compare the Company’s performance in the current period to that of prior periods for trend analysis. These measures are also used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these stand-alone financial measures provides an additional tool for investors to use in evaluating Formula’s financial position.
Management of the Company does not consider these stand-alone measures in isolation or as an alternative to financial measures determined in accordance with IFRS.
About Formula
For more information, visit www.formulasystems.com.
Press Contact:
+972-3-5389305
ir@formula.co.il
Forward Looking Statements
Certain matters discussed in this press release that are incorporated herein and therein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the
While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Item 3.D Risk Factors” in our most recent Annual Report on Form 20-F for the year ended
CONSOLIDATED CONDENSED STATEMENTS OF PROFIT OR LOSS
| Three months ended | ||||||||
| 2026 | 2025(*) | |||||||
| Unaudited | ||||||||
| Revenues | 738,285 | 619,383 | ||||||
| Cost of revenues | 592,249 | 499,154 | ||||||
| Gross profit | 146,036 | 120,229 | ||||||
| Research and development expenses, net | 5,169 | 4,811 | ||||||
| Selling, marketing and general and administrative expenses | 75,647 | 65,894 | ||||||
| Other income, net | 16,785 | - | ||||||
| Operating income | 82,005 | 49,524 | ||||||
| Financial expenses, net | 4,170 | 6,494 | ||||||
| Income before taxes on income | 77,835 | 43,030 | ||||||
| Taxes on income | 15,377 | 10,969 | ||||||
| Income after taxes | 62,458 | 32,061 | ||||||
| Share of profit of companies accounted for at equity, net | 297 | 828 | ||||||
| Net income from continued operations | 62,755 | 32,889 | ||||||
| Net income from discontinued operations | - | 17,493 | ||||||
| Net income | 62,755 | 50,382 | ||||||
| Net income attributable to non-controlling interests from continued operations | 27,116 | 21,141 | ||||||
| Net income attributable to non-controlling interests from discontinued operations | - | 9,925 | ||||||
| Net income attributable to non-controlling interests | 27,116 | 31,066 | ||||||
| Net income attributable to Formula’s shareholders from continued operations | 35,639 | 11,748 | ||||||
| Net income attributable to Formula’s shareholders from discontinued operations | 0 | 7,568 | ||||||
| Net income attributable to Formula’s shareholders | 35,639 | 19,316 | ||||||
| Earnings per share from continued operations (basic) | 2.33 | 0.77 | ||||||
| Earnings per share from discontinued operations (basic) | - | 0.49 | ||||||
| Earnings per share (basic) | 2.33 | 1.26 | ||||||
| Earnings per share from continued operations (diluted) | 2.25 | 0.75 | ||||||
| Earnings per share from discontinued operations (diluted) | - | 0.48 | ||||||
| Earnings per share (diluted) | 2.25 | 1.23 | ||||||
| Number of shares used in computing earnings per share (basic) | 15,317,067 | 15,311,924 | ||||||
| Number of shares used in computing earnings per share (diluted) | 15,838,550 | 15,729,173 | ||||||
| (*) | Following the completion of the acquisition of |
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| CURRENT ASSETS: | ||||||||
| Cash and cash equivalents | 1,181,911 | 1,280,121 | ||||||
| Short-term deposits | 631 | 372 | ||||||
| Marketable securities | 363 | - | ||||||
| Trade receivables, net | 844,559 | 774,471 | ||||||
| Prepaid expenses and other accounts receivable | 110,699 | 80,604 | ||||||
| Inventories | 36,304 | 30,249 | ||||||
| Total current assets | 2,174,467 | 2,165,817 | ||||||
| NON-CURRENT ASSETS: | ||||||||
| Financial assets measured at fair value through profit or loss | 303,751 | 304,549 | ||||||
| Long-term investments and receivables | 48,407 | 50,126 | ||||||
| Deferred taxes | 26,974 | 26,915 | ||||||
| Investments in companies accounted for at equity | 66,124 | 48,908 | ||||||
| Property, plants and equipment, net | 54,837 | 47,614 | ||||||
| Right-of-use assets | 144,458 | 145,462 | ||||||
| Intangible assets, net and goodwill | 819,128 | 793,864 | ||||||
| Total non-current assets | 1,463,679 | 1,417,438 | ||||||
| Total assets | 3,638,146 | 3,583,255 | ||||||
| LIABILITIES AND EQUITY | ||||||||
| CURRENT LIABILITIES: | ||||||||
| Loans from banks and others | 240,568 | 177,899 | ||||||
| Debentures | 78,703 | 76,696 | ||||||
| Current maturities of lease liabilities | 43,573 | 42,899 | ||||||
| Trade payables | 367,127 | 368,319 | ||||||
| Deferred revenues | 185,566 | 157,545 | ||||||
| Employees and payroll accrual | 236,123 | 235,705 | ||||||
| Other accounts payable | 76,886 | 195,817 | ||||||
| Dividend payable | - | 7,886 | ||||||
| Liabilities in respect of business combinations | 4,274 | 6,359 | ||||||
| Put options of non-controlling interests | 59,060 | 61,206 | ||||||
| Total current liabilities | 1,291,880 | 1,330,331 | ||||||
| LONG-TERM LIABILITIES: | ||||||||
| Loans from banks and others | 26,590 | 68,309 | ||||||
| Debentures | 107,939 | 118,656 | ||||||
| Convertible debentures | 78,344 | - | ||||||
| Lease liabilities | 105,763 | 107,805 | ||||||
| Other long-term liabilities | - | 54 | ||||||
| Deferred taxes | 88,143 | 83,426 | ||||||
| Deferred revenues | 14,693 | 16,457 | ||||||
| Liabilities in respect of business combinations | 15,249 | 13,291 | ||||||
| Put options of non-controlling interests | 79,003 | 61,577 | ||||||
| Employee benefit liabilities | 6,485 | 5,547 | ||||||
| Total long-term liabilities | 522,209 | 475,122 | ||||||
| EQUITY | ||||||||
| Total equity attributable to | 1,384,909 | 1,353,263 | ||||||
| Non-controlling interests | 439,148 | 424,539 | ||||||
| Total equity | 1,824,057 | 1,777,802 | ||||||
| Total liabilities and equity | 3,638,146 | 3,583,255 | ||||||
STAND-ALONE STATEMENTS OF FINANCIAL POSITION
| 2026 | 2025 | |||||||
| (Unaudited) | (Unaudited) | |||||||
| ASSETS | ||||||||
| CURRENT ASSETS: | ||||||||
| Cash and cash equivalents | 740,881 | 793,131 | ||||||
| Dividend receivable | 12,011 | 448 | ||||||
| Other accounts receivable and prepaid expenses | 5,689 | 5,527 | ||||||
| Total current assets | 758,581 | 799,106 | ||||||
| NON-CURRENT ASSETS: | ||||||||
| Investment in subsidiaries and a jointly controlled entity (*) | ||||||||
| Matrix IT Ltd. | 317,756 | 183,214 | ||||||
| - | 132,183 | |||||||
| TSG IT Advanced Systems Ltd. | 51,607 | 33,882 | ||||||
| Michpal Technologies Ltd. | 109,242 | 108,099 | ||||||
| 46,666 | 48,154 | |||||||
| Other | 80,910 | 50,428 | ||||||
| Total investment in subsidiaries and a jointly controlled entity | 606,181 | 555,960 | ||||||
| Financial assets measured at fair value through profit or loss | 300,000 | 300,000 | ||||||
| Other investments and long term receivables | 21,150 | 23,904 | ||||||
| Property, plants and equipment, net | 32 | 13 | ||||||
| Total non-current assets | 927,363 | 879,877 | ||||||
| Total assets | 1,685,944 | 1,678,983 | ||||||
| LIABILITIES AND EQUITY | ||||||||
| CURRENT LIABILITIES: | ||||||||
| Loans from banks and others | 105,975 | 15,158 | ||||||
| Debentures | 53,742 | 52,350 | ||||||
| Trade payables | 1,397 | 963 | ||||||
| Other accounts payable | 42,534 | 152,634 | ||||||
| Put options of non-controlling interests | 2,165 | 992 | ||||||
| Dividends payable | - | 7,883 | ||||||
| Total current liabilities | 205,813 | 229,980 | ||||||
| LONG-TERM LIABILITIES: | ||||||||
| Loans from banks and others | 219 | 871 | ||||||
| Debentures | 46,618 | 46,204 | ||||||
| Deferred taxes Liability | 48,385 | 48,665 | ||||||
| Total long-term liabilities | 95,222 | 95,740 | ||||||
| EQUITY | 1,384,909 | 1,353,263 | ||||||
| TOTAL LIABILITIES AND EQUITY | 1,685,944 | 1,678,983 | ||||||
| (*) | The investments’ carrying amounts are measured consistent with the accounting principles applied in the consolidated financial statements of the Group and representing the investments’ cost adjusted by Formula’s share in the investees’ accumulated undistributed earnings and other comprehensive income or loss. |
Source: 